Epidrug mediated re-expression of miRNA targeting the HMGA transcripts in pituitary cells

Kitchen, Mark O. and Yacub-Usman, Kiren and Emes, Richard D. and Richardson, Alan and Clayton, Richard N. and Farrell, William E. (2015) Epidrug mediated re-expression of miRNA targeting the HMGA transcripts in pituitary cells. Pituitary, 18 (5). pp. 674-684. ISSN 1573-7403

PDF - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
Download (882kB) | Preview


Transgenic mice overexpressing the high mobility group A (HMGA) genes, Hmga1 or Hmga2 develop pituitary tumours and their overexpression is also a frequent finding in human pituitary adenomas. In some cases, increased expression of HMGA2 but not that of HMGA1 is consequent to genetic perturbations. However, recent studies show that down-regulation of microRNA (miRNA), that contemporaneously target the HMGA1 and HMGA2 transcripts, are associated with their overexpression. In a cohort of primary pituitary adenoma we determine the impact of epigenetic modifications on the expression of HMGA-targeting miRNA. For these miRNAs, chromatin immunoprecipitations showed that transcript down-regulation is correlated with histone tail modifications associated with condensed silenced genes. The functional impact of epigenetic modification on miRNA expression was determined in the rodent pituitary cell line, GH3. In these cells, histone tail, miRNA-associated, modifications were similar to those apparent in human adenoma and likely account for their repression. Indeed, challenge of GH3 cells with the epidrugs, zebularine and TSA, led to enrichment of the histone modification, H3K9Ac, associated with active genes, and depletion of the modification, H3K27me3, associated with silent genes and re-expression of HMGA-targeting miRNA. Moreover, epidrugs challenges were also associated with a concomitant decrease in hmga1 transcript and protein levels and concurrent increase in bmp-4 expression. These findings show that the inverse relationship between HMGA expression and targeting miRNA is reversible through epidrug interventions. In addition to showing a mechanistic link between epigenetic modifications and miRNA expression these findings underscore their potential as therapeutic targets in this and other diseases.

Item Type: Article
Additional Information: The final publication is available at Springer via http://dx.doi.org/10.1007/s11102-014-0630-5
Keywords: pituitary, microRNA, chromatin, epidrugs, HMGA1
Schools/Departments: University of Nottingham UK Campus > Faculty of Medicine and Health Sciences > School of Veterinary Medicine and Science
Identification Number: https://doi.org/10.1007/s11102-014-0630-5
Depositing User: Emes, Richard
Date Deposited: 18 Dec 2015 14:11
Last Modified: 13 Sep 2016 16:06
URI: http://eprints.nottingham.ac.uk/id/eprint/31143

Actions (Archive Staff Only)

Edit View Edit View